Towards Healthcare
Vaccines Market Size to Increase USD 126.26 Bn by 2035

Vaccines Market Expands Amid Global Immunization Push

Projections indicate that, the global vaccines market will increase from USD 84.97 billion in 2025 to USD 126.26 billion by 2035, experiencing a CAGR of 4.04% over the next 10 years. The rising prevalence of infectious disorders and favorable immunization programs drive the market. North America dominated the global market owing to the availability of a robust healthcare infrastructure and the presence of key players.

Content

  • Last Updated: 14 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The vaccines market stands at USD 84.97 billion in 2025 and is expected to reach USD 126.26 billion by 2035, growing at a CAGR of 4.04% from 2024 to 2034.

North America is leading the vaccines market due to the availability of a robust healthcare infrastructure, the presence of key players, and favorable government policies.

The vaccines market includes 6 segments by vaccine type platform, by indication target disease, by product, by distribution commercial model, by manufacturing stage, and by region.

Some key players include Pfizer, Moderna, GSK, and CSL Seqirus

Vaccines help the immune system fight infections more efficiently to build protection. They recognize the invading germ, produce antibodies, and remember how to fight the disease.

World Health Organization, Centers for Disease Control and Prevention, clinicaltrials.gov, mohfw.gov.in, The Observatory of Economic Complexity
Any Questions